• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L-天冬酰胺酶:一种有前景的化疗药物。

L-asparaginase: a promising chemotherapeutic agent.

作者信息

Verma Neelam, Kumar Kuldeep, Kaur Gurnoor, Anand Sneh

机构信息

Biosensor Technology Lab, Department of Biotechnology, Punjabi University, Patiala, Punjab, India.

出版信息

Crit Rev Biotechnol. 2007 Jan-Mar;27(1):45-62. doi: 10.1080/07388550601173926.

DOI:10.1080/07388550601173926
PMID:17364689
Abstract

This article comprises detailed information about L-asparaginase, encompassing topics such as microbial and plant sources of L-asparaginase, treatment with L-asparaginase, mechanism of action of L-asparaginase, production, purification, properties, expression and characteristics of l-asparaginase along with information about studies on the structure of L-asparaginase. Although L-asparaginase has been reviewed by Savitri and Azmi (2003), our effort has been to include recent and updated information about the enzyme covering new aspects such as structural modification and immobilization of L-asparaginase, recombinant L-asparaginase, resistance to L-asparaginase, methods of assay of L-asparagine and L-asparaginase activity using the biosensor approach, L-asparaginase activity in soil and the factors affecting it. Also, side-effects of L-asparaginase treatment in acute lymphoblastic leukemia (ALL) have been discussed in the current review. L-asparaginase has been and is still one of the most widely studied therapeutic enzymes by researchers and scientists worldwide.

摘要

本文包含有关L-天冬酰胺酶的详细信息,涵盖L-天冬酰胺酶的微生物和植物来源、L-天冬酰胺酶治疗、L-天冬酰胺酶的作用机制、生产、纯化、性质、表达和特征等主题,以及关于L-天冬酰胺酶结构研究的信息。尽管Savitri和Azmi(2003年)已对L-天冬酰胺酶进行了综述,但我们的努力旨在纳入有关该酶的最新信息,涵盖新的方面,如L-天冬酰胺酶的结构修饰和固定化、重组L-天冬酰胺酶、对L-天冬酰胺酶的抗性、使用生物传感器方法测定L-天冬酰胺和L-天冬酰胺酶活性的方法、土壤中的L-天冬酰胺酶活性及其影响因素。此外,本综述还讨论了L-天冬酰胺酶治疗急性淋巴细胞白血病(ALL)的副作用。L-天冬酰胺酶一直是且仍然是全球研究人员和科学家研究最广泛的治疗性酶之一。

相似文献

1
L-asparaginase: a promising chemotherapeutic agent.L-天冬酰胺酶:一种有前景的化疗药物。
Crit Rev Biotechnol. 2007 Jan-Mar;27(1):45-62. doi: 10.1080/07388550601173926.
2
Marine microbial L-asparaginase: Biochemistry, molecular approaches and applications in tumor therapy and in food industry.海洋微生物 L-天冬酰胺酶:生物化学、分子方法及其在肿瘤治疗和食品工业中的应用。
Microbiol Res. 2018 Mar;208:99-112. doi: 10.1016/j.micres.2018.01.011. Epub 2018 Feb 2.
3
Microbial L-asparaginase: purification, characterization and applications.微生物 L-天冬酰胺酶:纯化、表征与应用。
Arch Microbiol. 2020 Jul;202(5):967-981. doi: 10.1007/s00203-020-01814-1. Epub 2020 Feb 12.
4
Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.海氏肠杆菌 L-天冬酰胺酶的克隆与特性研究,一种有前途的化疗药物。
Appl Microbiol Biotechnol. 2017 Oct;101(19):7227-7238. doi: 10.1007/s00253-017-8456-5. Epub 2017 Aug 11.
5
Use of L-asparaginase in childhood ALL.左旋天冬酰胺酶在儿童急性淋巴细胞白血病中的应用。
Crit Rev Oncol Hematol. 1998 Aug;28(2):97-113. doi: 10.1016/s1040-8428(98)00015-8.
6
Molecular expression of l-asparaginase gene from Nocardiopsis alba NIOT-VKMA08 in Escherichia coli: A prospective recombinant enzyme for leukaemia chemotherapy.来自白色诺卡氏菌NIOT-VKMA08的L-天冬酰胺酶基因在大肠杆菌中的分子表达:一种用于白血病化疗的潜在重组酶
Gene. 2016 Sep 30;590(2):220-6. doi: 10.1016/j.gene.2016.05.003. Epub 2016 May 4.
7
PEG-asparaginase.聚乙二醇天冬酰胺酶
Expert Opin Pharmacother. 2007 Aug;8(12):1977-84. doi: 10.1517/14656566.8.12.1977.
8
Circumventing the side effects of L-asparaginase.规避 L-天冬酰胺酶的副作用。
Biomed Pharmacother. 2021 Jul;139:111616. doi: 10.1016/j.biopha.2021.111616. Epub 2021 Apr 28.
9
Recent developments in L-asparaginase discovery and its potential as anticancer agent.L-天冬酰胺酶的发现及其作为抗癌剂的潜力的最新进展。
Crit Rev Oncol Hematol. 2016 Apr;100:1-10. doi: 10.1016/j.critrevonc.2015.01.002. Epub 2015 Jan 12.
10
Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.L-天冬酰胺酶治疗白血病的药理学及临床评价
Crit Rev Oncol Hematol. 2007 Mar;61(3):208-21. doi: 10.1016/j.critrevonc.2006.07.009. Epub 2006 Oct 2.

引用本文的文献

1
Enhanced production and purification of L-asparaginase from Bacillus paralicheniformis AUMC B-516 with potent cytotoxicity against MCF-7 cell lines.从具有对MCF-7细胞系强大细胞毒性的类拟芽孢杆菌AUMC B-516中提高L-天冬酰胺酶的产量和纯化度。
AMB Express. 2025 May 22;15(1):80. doi: 10.1186/s13568-025-01890-w.
2
L-asparaginase from the novel Fusarium falciforme AUMC 16563: extraction, purification, characterization, and cytotoxic effects on PC-3, HePG-2, HCT-116, and MCF-7 cell lines.来自新型镰刀菌镰刀状变种AUMC 16563的L-天冬酰胺酶:提取、纯化、表征及其对PC-3、HePG-2、HCT-116和MCF-7细胞系的细胞毒性作用。
BMC Microbiol. 2025 Mar 17;25(1):145. doi: 10.1186/s12866-025-03833-8.
3
Investigating Functional and Folding Stability of an Engineered L-asparaginase Harboring Y176F/S241C Mutations.
研究携带Y176F/S241C突变的工程化L-天冬酰胺酶的功能及折叠稳定性
Adv Pharm Bull. 2024 Oct;14(3):675-685. doi: 10.34172/apb.2024.048. Epub 2024 Jun 22.
4
The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy.钙网织蛋白靶向 L-天冬酰胺酶与抗 PD-L1 抗体联合调节肿瘤免疫微环境,协同增强放疗的抗肿瘤疗效。
Theranostics. 2024 Jan 20;14(3):1195-1211. doi: 10.7150/thno.90376. eCollection 2024.
5
Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs.乌拉圭儿童急性淋巴细胞白血病的药物遗传学:与诱导期药物相关的不良事件
Front Pharmacol. 2023 Nov 17;14:1278769. doi: 10.3389/fphar.2023.1278769. eCollection 2023.
6
Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems.用于提高异源系统中L-天冬酰胺酶表达的分子和代谢策略的当前状态。
Front Pharmacol. 2023 Jun 22;14:1208277. doi: 10.3389/fphar.2023.1208277. eCollection 2023.
7
Polyamidoamine Dendrimers Functionalized with ZnO-Chitosan Nanoparticles as an Efficient Surface for L-asparaginase Immobilization.用ZnO-壳聚糖纳米粒子功能化的聚酰胺胺树枝状大分子作为L-天冬酰胺酶固定化的高效表面
Appl Biochem Biotechnol. 2024 Feb;196(2):971-991. doi: 10.1007/s12010-023-04590-y. Epub 2023 Jun 7.
8
Clinical impacts of the concomitant use of L-asparaginase and total parenteral nutrition containing L-aspartic acid in patients with acute lymphoblastic leukemia.急性淋巴细胞白血病患者同时使用L-天冬酰胺酶和含L-天冬氨酸的全胃肠外营养的临床影响。
Front Nutr. 2023 Apr 3;10:1122010. doi: 10.3389/fnut.2023.1122010. eCollection 2023.
9
Insights into the Distribution and Functional Properties of l-Asparaginase in the Archaeal Domain and Characterization of Asparaginase Belonging to the Novel Family Asp2like1.古菌域中天冬酰胺酶的分布与功能特性洞察以及属于新型Asp2like1家族的天冬酰胺酶的表征
ACS Omega. 2022 Nov 2;7(45):40750-40765. doi: 10.1021/acsomega.2c01127. eCollection 2022 Nov 15.
10
Molecular cloning, characterization, and in-silico analysis of l-asparaginase from Himalayan sp. PCH44.来自喜马拉雅菌株PCH44的L-天冬酰胺酶的分子克隆、特性鉴定及电子克隆分析
3 Biotech. 2022 Aug;12(8):162. doi: 10.1007/s13205-022-03224-0. Epub 2022 Jul 9.